arrow
D

David Rial-Crestelo

university hospital 12 de octubre
H指数:12
被引数:372

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of dolutegravir/lamivudine versus bictegravir/emtricitabine/tenofovir alafenamide in people with HIV with very high viral load (≥500 000 copies/mL)

多替拉韦/拉米夫定与比克替拉韦/恩曲他滨/替诺福韦艾拉酚胺在病毒载量极高(≥500000 copies/mL)的HIV感染者中的疗效比较

2026-08-210
PRE
Low-effort HIV training in Spanish primary care: Long-term impact on testing and diagnosis

低投入的艾滋病培训在西班牙初级保健中的应用:对检测和诊断的长期影响

2025-08-300
PRE
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis
2023-10-2711
OAAI
Incidence of Anal Cancer and Related Risk Factors in HIV-Infected Patients Enrolled in the National Prospective Spanish Cohort CoRIS

参加全国前瞻性西班牙队列CoRIS的HIV感染患者中肛门癌的发生率和相关危险因素

2023-08-034
PRE
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO) (vol 55, 102779, 2020)
2023-03-011
OAAI
Daily tenofovir disoproxil fumarate/emtricitabine and hydroxychloroquine for pre-exposure prophylaxis of COVID-19: a double-blind placebo-controlled randomized trial in healthcare workers
2023-01-019
OAAI
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance
2022-11-086
OAAI
Changes in Quality of Sleep, Mood, and Other Neuropsychiatric Symptoms After Switching Dolutegravir/Lamivudine/Abacavir to Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Randomized Study of People With Human Immunodeficiency Virus With Poor Sleep Quality: GESIDA 10418
2022-08-068
OAAI
Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19-Convalescent Individuals

在幼稚和COVID-19-Convalescent个体中接种BNT162b2疫苗后8个月对SARS-CoV-2变体的中和反应

2021-12-2813
OAAI
Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study)
2021-08-306
PRE
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study
2020-11-1725
PREAI
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)
2020-05-0128
OAAI